Clinical trials
Female clinical trials
Below are recruiting female clinical trials, each written for real people, not researchers. We’re tracking 466 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06935682RecruitingPhase 1
Safety study of Y-4 tablets in healthy volunteers
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
Beijing, Beijing MunicipalityAges 18–45 - NCT06935721RecruitingPhase 1
Medication interaction study for healthy adults
This trial studies how a new tablet called Y-4 interacts with pregabalin and riluzole in healthy people. It helps doctors understand how these drugs work together in the body.
Beijing, Beijing MunicipalityAges 18–45 - NCT07201584RecruitingPhase 1
Bioavailability study of two torasemide 10 mg tablets in healthy adults
This study compares how two different 10 mg tablets of the diuretic torasemide are absorbed by the body in healthy adults who have not eaten. It helps researchers see if the tablets work the same way.
Almaty, Ili District, Otegen Batyr SettlementAges 18–55 - NCT07202884RecruitingPhase 3
Orforglipron for Women with Stress Incontinence and Overweight
This study tests an oral medication called orforglipron to see if it helps women with stress urinary incontinence who are also overweight or have obesity. The medicine may reduce leaking episodes and also help with weight loss.
Birmingham, AlabamaAges 18 years+ - NCT07202949RecruitingPhase 2
Extended antibiotics with methenamine for chronic urinary tract infection
This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.
LondonAges 18 years+ - NCT07198724RecruitingPhase 1/Phase 2
A study of elacestrant plus Enhertu for advanced breast cancer
This trial tests a new combination of two targeted drugs (elacestrant and Enhertu) for people with a specific type of advanced breast cancer (HR-positive, HER2-low or ultra-low) that did not respond to standard treatments like CDK4/6 inhibitors. The goal is to see if this combination works better than current options.
Boston, MassachusettsAges 18 years+ - NCT06721936Recruiting
Study for menopause symptoms after breast cancer
This trial tests a treatment for menopause-like vaginal symptoms that can happen after breast cancer treatment. It aims to help survivors feel more comfortable.
MadridAges 38 years+ - NCT06687278Recruiting
Talk therapy for women who experienced partner violence
This study tests a type of talk therapy (interpersonal relationship psychotherapy) to help women who have been harmed by a partner. The goal is to improve mental health and well-being.
IstanbulAges 18 years+ - NCT07175571Recruiting
Comparing insemination methods with frozen donor sperm in IVF
This study compares different insemination methods when using frozen donor sperm during IVF. It aims to find the best technique to help more eggs get fertilized.
Rockville, MarylandAges Any age - NCT07183683Recruiting
Acupuncture for bladder problems in women with MS
This study tests whether stimulating acupuncture points on the lower leg can help women with multiple sclerosis who have overactive bladder symptoms like urgency, frequent urination, or leaking. It is for women with relapsing-remitting MS who are not using a catheter regularly.
Berlin, State of BerlinAges 18–60 - NCT07176689RecruitingPhase 4
Nirogacestat for desmoid tumors in premenopausal women
This trial tests a drug called nirogacestat to see if it can help premenopausal women with desmoid tumors (a type of non-cancerous growth) that are causing symptoms or getting worse. It aims to offer a new treatment option for those who need systemic therapy.
BrusselsAges 18–40 - NCT06738576RecruitingPhase 1
Stem cell treatment for women over 50 with stress urinary incontinence
This trial tests whether a single injection of stem cells from donated fat tissue can help women over 50 with stress urinary incontinence. It is for those who haven't gotten better with exercises or who want to avoid surgery.
Coslada, MadridAges 50 years+ - NCT07156084RecruitingPhase 4
HPV vaccine long-term effect study for young adults
This study checks if one dose of the 9-valent HPV vaccine given at ages 9-11 still protects you 6 years later. It is for people who only had that single dose and no other HPV shots.
Québec, QuebecAges 15–17 - NCT07163117Recruiting
Back exercises for female university students with back pain
This study tests two different types of back exercises to see which works better for reducing mechanical low back pain (pain not caused by injury or disease) in female university students. It may help you find a good exercise routine if you have had this type of back pain for a while.
CairoAges 18–24 - NCT06921746Recruiting
Urinary microbiome and metabolism changes in overactive bladder treatment
This study looks at how the bacteria and chemicals in your urine change when women receive treatment for overactive bladder. It may help researchers understand why some treatments work better for some people.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT03144648Recruiting
Study of breast cancer subtypes in premenopausal women in Latin America
This study looks at different biological “subtypes” of breast cancer in women who are still having periods. It helps researchers understand the cancer type and may guide more personalized care in the future.
BarretosAges 20–45 - NCT07151963Enrolling by invitation
Can brain stimulation reduce chemo nerve pain in breast cancer?
This study tests a gentle brain stimulation treatment (called theta burst) to see if it can reduce nerve pain caused by breast cancer chemotherapy. If you have ongoing tingling or burning in your hands or feet, this treatment aims to calm those symptoms without using more medication.
New Taipei CityAges 18–80 - NCT07144527Recruiting
NMN supplement for exercise in healthy older adults
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.
Beverly Hills, CaliforniaAges 60–80 - NCT06957795Recruiting
Pelvic floor training before surgery for urine leakage
This trial tests if doing pelvic floor exercises before surgery helps women with stress urinary incontinence (leakage when coughing, sneezing, or exercising). It aims to see if preparing the pelvic floor muscles leads to better results after surgery.
AnkaraAges 18–65 - NCT07131384Recruiting
Nitrate supplement and metformin for prediabetes
This trial tests whether adding a nitrate supplement to metformin helps people with prediabetes. It looks at how the two treatments interact, especially when you start exercising. The study might help you if you have prediabetes, are between 18 and 60 years old, and don't exercise much.
Charlottesville, VirginiaAges 18–60 - NCT07128394Recruiting
Extra LH hormone for better embryos in IVF with low LH
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
Nanjing, JiangsuAges 20–37 - NCT07132385Recruiting
Exercise types for perimenopausal women with symptoms
This study is testing whether different types of exercise (like walking, strength training, or a mix) are practical and helpful for women going through perimenopause who have menopause symptoms and risk factors for heart or metabolic disease.
Toronto, OntarioAges 40 years+ - NCT07133087Recruiting
Body awareness and quality of life in breast cancer survivors
This study looks at how body awareness, arm function, and quality of life are connected in women who have completed treatment for early-stage breast cancer. It may help guide future support services.
IstanbulAges 25–75 - NCT05938192Recruiting
Treatments for HPV-related genital tract changes
This trial studies treatment approaches for conditions caused by human papillomavirus (HPV) in the female genital tract. It may help people whose HPV-related disease is being evaluated for new or combined treatment options.
Milan, LombardyAges 18 years+
Hear when a new Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for female?
- Yes. Clin2 currently lists 466 recruiting female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.